Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aya Suzuki

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
JTO Clinical and Research Reports|April 14, 2025
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902Yoko Tsukita, Rei Umezawa, Taku Nakagawa, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2017
An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1aYuichi Yamazaki, Aya Suzuki, Kimitoshi Hirayanagi, et al.
The Oncologist|February 28, 2013
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B studyHiromi Nagashima, Tatsuro Fukuhara, Yu Utsumi, et al.
Cancer Science|May 4, 2023
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trialKazutaka Fujita, Ryo Arai, Satoshi Shoji, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
JTO Clinical and Research Reports|April 14, 2025
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902Yoko Tsukita, Rei Umezawa, Taku Nakagawa, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2017
An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1aYuichi Yamazaki, Aya Suzuki, Kimitoshi Hirayanagi, et al.
The Oncologist|February 28, 2013
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2025
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B studyHiromi Nagashima, Tatsuro Fukuhara, Yu Utsumi, et al.
Cancer Science|May 4, 2023
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trialKazutaka Fujita, Ryo Arai, Satoshi Shoji, et al.
Pageof 6